121 related articles for article (PubMed ID: 7941779)
1. Antitussive effect of (+/-) pentazocine in diabetic mice is mediated by delta-sites, but not by mu- or kappa-opioid receptors.
Kamei J; Iwamoto Y; Misawa M; Nagase H; Kasuya Y
Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Jun; 14(3):147-52. PubMed ID: 7941779
[TBL] [Abstract][Full Text] [Related]
2. Effects of diabetes on the antinociceptive effect of (+/-)pentazocine in mice.
Kamei J; Iwamoto Y; Misawa M; Nagase H; Kasuya Y
Res Commun Chem Pathol Pharmacol; 1994 Apr; 84(1):105-10. PubMed ID: 8042002
[TBL] [Abstract][Full Text] [Related]
3. The antitussive activity of delta-opioid receptor stimulation in guinea pigs.
Kotzer CJ; Hay DW; Dondio G; Giardina G; Petrillo P; Underwood DC
J Pharmacol Exp Ther; 2000 Feb; 292(2):803-9. PubMed ID: 10640321
[TBL] [Abstract][Full Text] [Related]
4. Involvement of mu1-opioid receptor on oxycodone-induced antinociception in diabetic mice.
Nozaki C; Kamei J
Eur J Pharmacol; 2007 Apr; 560(2-3):160-2. PubMed ID: 17292346
[TBL] [Abstract][Full Text] [Related]
5. Role of intracellular calcium in modification of mu and delta opioid receptor-mediated antinociception by diabetes in mice.
Ohsawa M; Nagase H; Kamei J
J Pharmacol Exp Ther; 1998 Aug; 286(2):780-7. PubMed ID: 9694934
[TBL] [Abstract][Full Text] [Related]
6. Antitussive effect of beta-endorphin is mediated by mu-opioid receptors, but not by kappa- or epsilon-opioid receptors.
Kamei J; Iwamoto Y; Misawa M; Nagase H; Kasuya Y
Eur J Pharmacol; 1993 Mar; 233(2-3):251-4. PubMed ID: 8385624
[TBL] [Abstract][Full Text] [Related]
7. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
Baker AK; Meert TF
J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
[TBL] [Abstract][Full Text] [Related]
8. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
Mizoguchi H; Spaulding A; Leitermann R; Wu HE; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2003 Jul; 306(1):394-400. PubMed ID: 12721333
[TBL] [Abstract][Full Text] [Related]
9. Antitussive effect of dihydroetorphine in mice.
Kamei J; Iwamoto Y; Suzuki T; Misawa M; Nagase H; Kasuya Y
Eur J Pharmacol; 1994 Aug; 260(2-3):257-9. PubMed ID: 7988653
[TBL] [Abstract][Full Text] [Related]
10. Functional interaction among opioid receptor types: up-regulation of mu- and delta-opioid receptor functions after repeated stimulation of kappa-opioid receptors.
Khotib J; Narita M; Suzuki M; Yajima Y; Suzuki T
Neuropharmacology; 2004 Mar; 46(4):531-40. PubMed ID: 14975677
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a novel bivalent morphinan possessing kappa agonist and micro agonist/antagonist properties.
Mathews JL; Peng X; Xiong W; Zhang A; Negus SS; Neumeyer JL; Bidlack JM
J Pharmacol Exp Ther; 2005 Nov; 315(2):821-7. PubMed ID: 16076937
[TBL] [Abstract][Full Text] [Related]
12. The antitussive effects of endomorphin-1 and endomorphin-2 in mice.
Kamei J; Morita K; Saitoh A; Nagase H
Eur J Pharmacol; 2003 Apr; 467(1-3):219-22. PubMed ID: 12706478
[TBL] [Abstract][Full Text] [Related]
13. Substance P(1-7) induces antihyperalgesia in diabetic mice through a mechanism involving the naloxone-sensitive sigma receptors.
Carlsson A; Ohsawa M; Hallberg M; Nyberg F; Kamei J
Eur J Pharmacol; 2010 Jan; 626(2-3):250-5. PubMed ID: 19836387
[TBL] [Abstract][Full Text] [Related]
14. Effect of diabetes on pinacidil-induced antinociception in mice.
Zushida K; Onodera K; Kamei J
Eur J Pharmacol; 2002 Oct; 453(2-3):209-15. PubMed ID: 12398906
[TBL] [Abstract][Full Text] [Related]
15. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
16. SNF9007: a novel analgesic that acts simultaneously at delta 1, delta 2 and mu opioid receptors.
Williams CL; Rosenfeld GC; Dafny N; Fang SN; Hruby VJ; Bowden G; Cullinan CA; Burks TF
J Pharmacol Exp Ther; 1994 May; 269(2):750-5. PubMed ID: 8182541
[TBL] [Abstract][Full Text] [Related]
17. Antitussive effects of naltrindole, a selective delta-opioid receptor antagonist, in mice and rats.
Kamei J; Iwamoto Y; Suzuki T; Misawa M; Nagase H; Kasuya Y
Eur J Pharmacol; 1993 Nov; 249(2):161-5. PubMed ID: 8287897
[TBL] [Abstract][Full Text] [Related]
18. Effect of diabetes on the morphine-induced inhibition of gastrointestinal transit.
Kamei J; Ohsawa M; Misawa M; Nagase H; Kasuya Y
Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Apr; 15(2):165-9. PubMed ID: 7796321
[TBL] [Abstract][Full Text] [Related]
19. [Mechanisms of central antitussives].
Kamei J
Nihon Yakurigaku Zasshi; 1998 Jun; 111(6):345-55. PubMed ID: 9720082
[TBL] [Abstract][Full Text] [Related]
20. Involvement of mu-opioid receptors in the antitussive effects of pentazocine.
Kamei J; Katsuma K; Kasuya Y
Naunyn Schmiedebergs Arch Pharmacol; 1992 Feb; 345(2):203-8. PubMed ID: 1314961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
